Repligen Corporation Prepares for Key Investor Conferences
Today, we take a closer look at Repligen Corporation, a prominent life sciences company specializing in bioprocessing technology. The firm recently announced its attendance at five significant investor conferences, showcasing its commitment to advancing bioprocessing technology and connecting with potential investors.
Conference Details
Among the upcoming conferences, the UBS Global Healthcare Conference stands out. Taking place in Palm Beach Gardens, it features Jason Garland, the Chief Financial Officer of Repligen Corporation, who will be involved in a critical analyst-led discussion. This event is scheduled for the morning of November 10.
Stifel Healthcare Conference Participation
Shortly after, the Stifel Healthcare Conference in New York is another important event on the calendar. Taking place from November 11 to 13, Olivier Loeillot, the company’s President and CEO, is set to participate in discussions that will focus on the latest trends in biopharmaceuticals and how Repligen is innovating within this space.
Wolfe Research Healthcare Conference Insights
Following this, the Wolfe Research Healthcare Conference will also be held in New York from November 17 to 19. Here, Jason Garland will once again step into the spotlight for an important discussion that delves into the company’s financial strategies and future projections.
Jefferies Global Healthcare Conference
As a highlight, Repligen Corporation will also present at the Jefferies Global Healthcare Conference from November 18 to 20 in London. Olivier Loeillot will discuss the company’s vision and strategic initiatives aimed at enhancing bioprocessing efficiency.
Stephens Annual Investment Conference
The last, but certainly not least, is the Stephens Annual Investment Conference, which will take place from November 18 to 20 in Nashville. Jason Garland will have a series of one-on-one meetings with investors, providing a unique opportunity for personalized discussions regarding Repligen's innovative strategies and vision for growth.
Live Webcasts and Access
For those interested, live webcasts of these conferences will be available through the Repligen Investor Relations page. This offers a fantastic opportunity for investors and stakeholders to gain insight into the company’s operations, strategies, and outlook. Recordings of these presentations will also be accessible following the events for a limited time.
About Repligen Corporation
Repligen Corporation is dedicated to advancing bioprocessing technologies and systems that enhance the manufacturing process for biological drugs. With a focus on filtration, fluid management, chromatography, process analytics, and proteins, the company is driving innovation in the pharmaceutical sector. The company is headquartered in Waltham, Massachusetts, and maintains several global manufacturing sites.
As Repligen Corporation continues to inspire advances in bioprocessing, its commitment to providing cutting-edge solutions for biopharmaceutical developers remains steadfast.
Frequently Asked Questions
What are the upcoming investor conferences for Repligen Corporation?
Repligen Corporation is attending the UBS, Stifel, Wolfe Research, Jefferies, and Stephens conferences.
Who will represent Repligen at the UBS conference?
Jason Garland, the Chief Financial Officer, will participate in the analyst-led discussion.
Where is Repligen Corporation headquartered?
The company is based in Waltham, Massachusetts.
What is the primary focus of Repligen Corporation?
Repligen focuses on developing bioprocessing technologies that improve the manufacturing of biological drugs.
How can investors access the conference webcasts?
Investors can watch live webcasts through Repligen's Investor Relations page, with replays available afterward.
